Skip to main content

Table 3 Antibiotic resistance patterns of E. coli, K. pneumoniae, P. aeruginosa, and A. baumannii

From: Assessment of antibiotic resistance changes during the Covid-19 pandemic in northeast of Iran during 2020–2022: an epidemiological study

Species (number of isolates)

Antibiotic resistance patterns

AP

SAM

PTZ

CZ

CPM

CRO

FOX

IMI

MEM

GM

AK

CIP

NI

LEV

CTX

CAZ

E. coli (615)

Resistant

69 (89.6%)

56 (58.9%)

22 (36.7%)

313 (74.0%)

60 (71.4%)

393 (67.6%)

30 (47.6%)

222 (42.7%)

154 (33.6%)

88 (17.7%)

19 (31.7%)

15 (45.5%)

96 (20.2%)

33 (70.2%)

 

Intermediate

1 (1.3)

13 (13.7%)

8 (13.3%)

1 (0.2%)

8 (9.5%)

22 (3.8%)

5 (7.9%)

132 (25.4%)

78 (17.0%)

17 (3.4%)

6 (10.0%)

8 (24.2%)

67 (14.1%)

3 (6.4%)

 

Susceptible

7 (9.1%)

26 (27.4%)

30 (50.0%)

109 (25.8%)

16 (19.0%)

166 (28.6%)

28 (44.4%)

166 (31.9%)

227 (49.5%)

391 (78.8%)

35 (58.3%)

10 (30.3%)

313 (65.8%)

11 (23.4%)

K. pneumoniae

Resistant

101 (98.1%)

132 (81.0%)

81 (72.3%)

161 (80.5%)

122 (86.5%)

255 (78.9%)

80 (70.8%)

213 (71.7%)

197 (69.4%)

98 (38.3%)

50 (53.2%)

12 (70.6%)

93 (72.7%)

13 (92.9%)

13 (76.5%)

73 (92.4%)

(351)

Intermediate

0 (0.0%)

13 (8.0%)

17 (15.2%)

2 (1.0%)

10 (7.1%)

11 (3.4%)

7 (6.2%)

37 (12.5%)

29 (10.2%)

10 (3.9%)

7 (7.4%)

2 (11.8%)

9 (7.0%)

0 (0.0%)

0 (0.0%)

1 (1.3%)

 

Susceptible

2 (1.9%)

18 (11%)

14 (12.5%)

37 (18.5%)

9 (6.4%)

57 (17.6%)

26 (23.0%)

47 (15.8%)

58 (20.4%)

148 (57.8%)

37 (39.4%)

3 (17.6%)

26 (20.3%)

1 (7.1%)

4 (23.5%)

5 (6.3%)

P. aeruginosa

Resistant

216 (79.1%)

243 (87.1%)

290 (91.8%)

303 (91.5%)

220 (70.5%)

239 (79.4%)

13 (61.9%)

240 (85.7%)

252 (86.3%)

(363)

Intermediate

18 (6.6%)

8 (2.9%)

5 (1.6%)

1 (0.3%)

9 (2.9%)

9 (3.0%)

4 (19.0%)

16 (5.7%)

10 (3.4%)

 

Susceptible

39 (14.3%)

28 (10.0%)

21 (6.6%)

27 (8.2%)

83 (26.6%)

53 (17.6%)

4 (19.0%)

24 (8.6%)

30 (10.3%)

A. baumannii

Resistant

187 (77.9%)

199 (89.6%)

155 (89.6%)

241 (93.4%)

206 (88.4%)

248 (88.9%)

139 (70.9%)

151 (73.3%)

3 (42.9%)

198 (88.0%)

233 (94.7%)

226 (94.6%)

(344)

Intermediate

24 (10.0%)

12 (5.4%)

5 (2.9%)

8 (3.1%)

6 (2.6%)

3 (1.1%)

4 (2.0%)

4 (1.9%)

2 (28.6%)

6 (2.7%)

9 (3.7%)

2 (0.8%)

 

Susceptible

29 (12.1)

11 (5.0%)

13 (7.5%)

9 (3.5%)

21 (9.0%)

28 (10.0%)

53 (27.0%)

51 (24.8%)

2 (28.6%)

21 (9.3%)

4 (1.6%)

11 (4.6%)

  1. AP (Ampicillin), SAM (Ampicillin-Sulbactam), PTZ (Pipracillin-Tazobactam), CZ (Cefazolin), CPM (Cefepime), CRO (Ceftriaxone), FOX (Cefoxitin), IMI (Imipenem), MEM (Meropenem), GM (Gentamicin), AK (Amikacin), CIP (Ciprofloxacin), NI (Nitrofurantoin), LEV (Levofloxacin), CTX (Cefotaxime), and CAZ (Ceftazidim)
  2. *Samples for which antibiotic resistance testing has not been performed are marked with "–"
  3. * Percentage of each column is calculated based on the sum of 3 rows.